Tempus AI Stock-Based Compensation 2023-2025 | TEM

Tempus AI annual/quarterly stock-based compensation history and growth rate from 2023 to 2025. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
  • Tempus AI stock-based compensation for the quarter ending June 30, 2025 was $0.045B, a 90.7% decline year-over-year.
  • Tempus AI stock-based compensation for the twelve months ending June 30, 2025 was $1.112B, a 127.7% increase year-over-year.
  • Tempus AI annual stock-based compensation for 2024 was $0.534B, a 0% decline from 2023.
  • Tempus AI annual stock-based compensation for 2023 was $0B, a 0% decline from 2022.
  • Tempus AI annual stock-based compensation for 2022 was $0B, a 0% decline from .
Tempus AI Annual Stock-Based Compensation
(Millions of US $)
2024 $534
2023 $N/A
2022 $N/A
Sector Industry Market Cap Revenue
Medical Medical Information Systems $13.179B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $43.991B 53.84
Doximity (DOCS) United States $12.725B 56.62
Hims & Hers Health (HIMS) United States $9.572B 78.43
IRhythm Technologies (IRTC) United States $5.461B 0.00
Hinge Health (HNGE) United States $4.399B 0.00
Privia Health (PRVA) United States $2.828B 209.46
Inspire Medical Systems (INSP) United States $2.771B 40.74
Heartflow (HTFL) $2.557B 0.00
Phreesia (PHR) United States $1.884B 0.00
Enovis (ENOV) United States $1.766B 9.34
10x Genomics (TXG) United States $1.744B 0.00
Omnicell (OMCL) United States $1.497B 28.84
Schrodinger (SDGR) United States $1.436B 0.00
Azenta (AZTA) United States $1.400B 61.08
Clover Health Investments (CLOV) United States $1.343B 0.00
Claritev (CTEV) United States $1.135B 0.00
Evolent Health (EVH) United States $1.134B 0.00
Fulgent Genetics (FLGT) United States $0.679B 0.00
Zepp Health (ZEPP) Netherlands $0.652B 0.00
Veradigm (MDRX) United States $0.531B 0.00
Standard BioTools (LAB) United States $0.481B 0.00
Talkspace (TALK) United States $0.445B 133.00
Butterfly Network (BFLY) United States $0.405B 0.00
Carlsmed (CARL) United States $0.354B 0.00
TruBridge (TBRG) United States $0.300B 52.53
Outset Medical (OM) United States $0.247B 0.00
Health Catalyst (HCAT) United States $0.239B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.234B 0.00
Nyxoah SA (NYXH) Belgium $0.213B 0.00
KORU Medical Systems (KRMD) United States $0.195B 0.00
CapsoVision (CV) United States $0.175B 0.00
MDxHealth SA (MDXH) Belgium $0.168B 0.00
CareCloud (CCLD) United States $0.163B 7.38
American Well (AMWL) United States $0.111B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.109B 0.00
EUDA Health Holdings (EUDA) Singapore $0.077B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.072B 0.00
Pulmonx (LUNG) United States $0.070B 0.00
P3 Health Partners (PIII) United States $0.060B 0.00
111 (YI) China $0.056B 0.00
HeartBeam (BEAT) United States $0.046B 0.00
Zhongchao (ZCMD) China $0.025B 0.00
Precipio (PRPO) United States $0.025B 0.00
PROFUSA (PFSA) United States $0.017B 0.00
Healthcare Triangle (HCTI) United States $0.013B 0.00
Bullfrog AI Holdings (BFRG) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Movano (MOVE) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00